Loading...


Diabetes Library
Qnexa

-
New York Nursing Home Library
HomeBrowse Contribute Submit About Us Contact

/Home/Diabetes Treatment/Diabetes Drug Treatment/New Diabetes Drugs/Qnexa


Vivus says obesity drug Qnexa meets goals in trial
Votes:9 Comments:0
Vivus says obesity drug Qnexa meets goals in trial December 11, 2008 Boston.com MOUNTAIN VIEW, Calif.—Drug developer Vivus Inc. said Thursday its obesity drug candidate Qnexa met its goals in READ MORE
http://www.boston.com/business/healthcare/articles/2008/12/11/vivus_sa...

Qnexa Meets Primary Endpoint By Demonstrating Superior Weight Loss Over Componen...
Votes:33 Comments:0
Qnexa Meets Primary Endpoint By Demonstrating Superior Weight Loss Over Components And Placebo In The 28-Week Equate Study (OB-301) 15 Dec 2008 - 4:00 PST Medicalnewstoday.com VIVUS, Inc. (NASD READ MORE
http://www.medicalnewstoday.com/articles/133036.php

Qnexa Reduces Hemoglobin A1c By 1.6% in 56 Weeks
Votes:32 Comments:0
Qnexa Reduces Hemoglobin A1c By 1.6% in 56 Weeks December 12, 2008 Market Watch MOUNTAIN VIEW, Calif., Dec 12, 2008 (BUSINESS WIRE) -- --Treated with Qnexa over One-Year VIVUS (VVUS 6.05, + READ MORE
http://www.marketwatch.com/news/story/Qnexa-Reduces-Hemoglobin-A1c-By/...
Qnexa: Qnexa is a new drug in clinical trials for glycemic management in people with Type 2 diabetes who are obese.
Illinois Nursing Home Library , Stem Cells Library
Sites of Interest
Autism Library
-
Search
Search
Search
Search
Login
Privacy Policy